跳至主要内容
临床试验/DRKS00025969
DRKS00025969尚未招募4 期

A prospective, multicenter clinical study comparing outcomes of two trifocal toric intraocular lens - BTVCPL-TRITORIC-2019-18

Biotech Europe Meditech Inc. Ltd.0 个研究点目标入组 84 人开始时间: 2021年8月4日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
21 Years 至 one(—)
性别
All

入选标准

  • 1. Age of patient >21 Years
  • 2. Patient diagnosed with cataract.
  • 3. Patient must have preoperative regular corneal astigmatism between 0.75 to 4.5 D as per corneal topography or keratometry
  • 4. Calculated IOL power is within the range of investigational IOLs.
  • 5. Patient willing to sign inform consent form.
  • 6. Clear intraocular media other than cataract.
  • 7. Female participants of childbearing potential must be willing to ensure that they use effective contraception during the study.

排除标准

  • 1. Previous intraocular or corneal surgery.
  • 2. Traumatic cataract
  • 3. Pregnancy (as stated by patient) or lactation.
  • 4. Concurrent participation in another drug or device investigation.
  • 5. Irregular astigmatism.
  • 6. Patient receiving chlorquine treatment.
  • 7. Subjects with any systemic disease that could increase operative risk or confound the outcome.
  • 8. Active ocular disease in the operative eye other than cataract.
  • 9. Vulnerable subjects as defined in section 12.3.9.
  • 10. Corneal Astigmatism > 4.5 D

研究者

发起方
Biotech Europe Meditech Inc. Ltd.

相似试验

尚未招募
4 期
A trial comparing two trifocal toric intraocular lens
CTRI/2022/02/040590Biotech Healthcare Holdings GmbH
尚未招募
不适用
Multicenter, prospective, randomized study comparing motorized spiral enteroscopy with double balloon enteroscopyK63.8K92.2Other specified diseases of intestineGastrointestinal haemorrhage, unspecified
DRKS00025890Medizinische Klinik 1 Universitätsmedizin Frankfurt32
招募中
不适用
Comparative study between Diode Laser Surgery and Filtering Surgery as a Primary Surgical Procedure for patients with GlaucomaOpen Angle GlaucomaC11.525.381C11.525.381.407
RBR-65rzrvCentro de Referência em Oftalmologia da Universidade Federal de Goiás (CEROF-UFG)
进行中(未招募)
1 期
INTOReTAK : INfliximab and TOcilizumab in Refractory/relapsing TAKayasu arteritisPatients with refractory or relapsing Takayasu Arteritis desease
EUCTR2018-003753-13-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS50
进行中(未招募)
不适用
A trial in which will be studied if the addition of a medicine that is used for improving platelet counts (eltrombopag) to the regular treatment for aplastic anemia (hATG + CsA) also improves the numbers of other cell lines and therefore the overall bone marrow function.Idiopathic (Severe) Aplastic Anemia, a bone marrow failure syndrome which results in the normal hematopoietic tissue completely missing from the bone marrow, accounting for the subsequent pancytopenia.MedDRA version: 18.0Level: PTClassification code 10002967Term: Aplastic anaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disorders
EUCTR2014-000363-40-ESEuropean Society for Blood and Marrow Transplantation200